ReviewEndocrine, metabolic & immune disorders drug targets2009

Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification.

Karine Breckpot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.